* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Pulmonary Vein Isolation Using a Visually
Remote ischemic conditioning wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Lutembacher's syndrome wikipedia , lookup
Cardiac surgery wikipedia , lookup
History of invasive and interventional cardiology wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
DOI: 10.1161/CIRCEP.113.000431 who underwent ablation near the end of the 200 patient series were excluded as baseline demographics and procedural data were not available at the time of data analysis; however, none of these excluded patients experienced any procedural complications. All of the studies were approved by institutional review committees at the participating institutions, and all subjects gave informed consent. The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree with the manuscript as written. Patient Selection & Study Design: All 4 clinical studies were open label, non-randomized Downloaded from http://circep.ahajournals.org/ by guest on November 1, 2016 studies of patients with symptomatic, recurrent, paroxysmal AF. There minimal re were only y mini ima mal differences in the inclusion criteria between the studies. Key inclusionn criteria age crite t riia were: te were we re:: ag ge 18 118-75 8 years, and recurrent that refractory r cur rec urre r ntt paroxysmal re parox oxxysmal atrial fibrillation th hat at was refractor o y to at least one antiarrhythmicc ddrug IV). All patients otherwise ruug (Class I â IV V). A lll pati tiientts were weeree ot the herw wis isee deemed deem med ttoo bee candidates candi diidatess for foor catheter caa ablation. Key criteria K exclusion exc xclu lu lusion u crit iteriia included: it inclu lu uded: de a left de left ft ventricular venttriicular ullar ejection eje jectio ionn fraction io f acti fr t onn <30%, <30%, % LA LA diameter dia di ia >5 cm, PV diameters >32 PVs, the major minor 322 mm (f (for oval PV P s, th he mean off tthe he maj ajoor and aj ndd mi inor ddimensions imen ensi en s ons were si used), the presence off an intracardiac thrombus, ablation, myocardial intt cardi dia th thromb mb b s prior io cardiac rdi dia abl ablation blati ti m ocardial diall iinfarction infarctio nff cti tio or cardiac surgery within the prior 3 months, moderate or severe valvular heart disease, or a stroke/transient ischemic attack within prior 6 months. Pre-procedural CT or MRI scans were performed to assess LA and PV anatomy and size. Following the procedure, patients were discharged on oral anticoagulation (warfarin), and at times, low molecular weight heparin until the international normalized ratio was t2.0. Following the procedure, anti-arrhythmic medications were typically continued for 1 to 3 months after which they were completely discontinued. There was a 3 month blanking period following ablation. Follow-up methods were variable between the four studies and included clinic visits at 3 or 6 month intervals, and either Holter or transtelephonic monitoring at variable intervals. 4